Similarly, the improved transduction efficiency of capsid engineered AAV6 vectors in DCs and potent inhibition of tumor growth and extension of animal survival in a mouse model were reported when AAV6 vectors were used to express prostatic acid phosphatase (PAP), which is often upregulated in prostate cancer [182]. The gene discussed is ACP3; the disease is prostate cancer.